Besonders selten, besonders wichtig

• Literatur

• 1 Robaei D, Carnt N, Minassian DC. et al. Therapeutic and optical keratoplasty in the management of Acanthamoeba keratitis: risk factors, outcomes, and summary of the literature. Ophthalmology 2015; 122: 17-24
• 2 Roth M, Holtmann C, Daas L. et al. Results From the German Fungal Keratitis Registry: Significant Differences Between Cases With and Without a History of Contact Lens Use. Cornea 2021; 40: 1453-1461
• 3 Dart JKG, Papa V, Rama P. et al. The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08 % (Polihexanide) and Placebo versus PHMB 0.02 % and Propamidine 0.1. Ophthalmology 2024; 131: 277-287
• 4 Heuer R, Paulmann M, Annecke T. et al. S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) – Part 1: Diagnosis, initial management, and immunomodulating systemic therapy. J Dtsch Dermatol Ges 2024; 22: 1448-1466
• 5 Shanbhag SS, Hall L, Chodosh J. et al. Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis. Ocul Surf 2020; 18: 517-522